DNA-hydrolyzing catalytic IgGs from schizophrenia patients do not affect cell viability of the SH-SY5Y human neuroblastoma cell line. (1st June 2022)
- Record Type:
- Journal Article
- Title:
- DNA-hydrolyzing catalytic IgGs from schizophrenia patients do not affect cell viability of the SH-SY5Y human neuroblastoma cell line. (1st June 2022)
- Main Title:
- DNA-hydrolyzing catalytic IgGs from schizophrenia patients do not affect cell viability of the SH-SY5Y human neuroblastoma cell line
- Authors:
- Epimakhova, E.
Ermakov, E.
Kazantseva, D.
Parshukova, D.
Dmitrieva, E.
Smirnova, L.
Ivanova, S.
Semke, A. - Abstract:
- Abstract : Introduction: DNA-hydrolyzing catalytic IgGs have caspase-dependent cytotoxic effects in autoimmune diseases. Recently, DNA-hydrolyzing IgGs have been discovered in schizophrenia. However, their cytotoxic properties have not been studied. Objectives: To assess the effect of serum IgGs with DNA-hydrolyzing activity of schizophrenia patients on the cell viability of the SH-SY5Y human neuroblastoma cell line. Methods: Serum of 8 patients with paranoid schizophrenia in the acute phase and 7 mentally and somatically healthy persons were used. IgG was purified from serum by affinity chromatography on Protein-G-Sepharose columns. The DNA hydrolyzing activity of IgG was assessed by the degree of hydrolysis of the pBluescript plasmid. The cell viability of the SH-SY5Y human neuroblastoma cell line after exposure to purified IgG preparations was assessed by high-throughput screening on the CellInsight CX7 platform (Thermo Scientific, USA) using the fluorescent dyes propidium iodide and Hoechst. Results: Of the 8 IgG preparation obtained, 4 drugs had high DNA-hydrolyzing activity. All tested IgG preparations from healthy donors were inactive. One-way ANOVA analysis of the proportion of dead cells of the SH-SY5Y line after exposure to antibodies (0.1 mg/ml) showed no significant differences in the proportion of dead cells (p=0.688 after 24 hours; p=0.831 after 48 hours). Similar results were obtained at a higher concentration of antibodies - 0.2 mg/ml. Conclusions: Thus, itAbstract : Introduction: DNA-hydrolyzing catalytic IgGs have caspase-dependent cytotoxic effects in autoimmune diseases. Recently, DNA-hydrolyzing IgGs have been discovered in schizophrenia. However, their cytotoxic properties have not been studied. Objectives: To assess the effect of serum IgGs with DNA-hydrolyzing activity of schizophrenia patients on the cell viability of the SH-SY5Y human neuroblastoma cell line. Methods: Serum of 8 patients with paranoid schizophrenia in the acute phase and 7 mentally and somatically healthy persons were used. IgG was purified from serum by affinity chromatography on Protein-G-Sepharose columns. The DNA hydrolyzing activity of IgG was assessed by the degree of hydrolysis of the pBluescript plasmid. The cell viability of the SH-SY5Y human neuroblastoma cell line after exposure to purified IgG preparations was assessed by high-throughput screening on the CellInsight CX7 platform (Thermo Scientific, USA) using the fluorescent dyes propidium iodide and Hoechst. Results: Of the 8 IgG preparation obtained, 4 drugs had high DNA-hydrolyzing activity. All tested IgG preparations from healthy donors were inactive. One-way ANOVA analysis of the proportion of dead cells of the SH-SY5Y line after exposure to antibodies (0.1 mg/ml) showed no significant differences in the proportion of dead cells (p=0.688 after 24 hours; p=0.831 after 48 hours). Similar results were obtained at a higher concentration of antibodies - 0.2 mg/ml. Conclusions: Thus, it has been shown in vitro that IgGs isolated from the serum of schizophrenia patients with or without DNA-hydrolyzing activity does not exhibit cytotoxic properties against the SH-SY5Y human neuroblastoma cell line. Support by Grant of RSF № 18-15-00053P. Disclosure: No significant relationships. … (more)
- Is Part Of:
- European psychiatry. Volume 65:Supplement 1(2022)
- Journal:
- European psychiatry
- Issue:
- Volume 65:Supplement 1(2022)
- Issue Display:
- Volume 65, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 65
- Issue:
- 1
- Issue Sort Value:
- 2022-0065-0001-0000
- Page Start:
- S775
- Page End:
- S775
- Publication Date:
- 2022-06-01
- Subjects:
- neuroblastoma cell line -- schizophrenia -- DNA-hydrolyzing activity
Psychiatry -- Periodicals
Mental illness -- Periodicals
Electronic journals
616.89 - Journal URLs:
- https://www.cambridge.org/core/journals/european-psychiatry ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09249338 ↗
http://www.sciencedirect.com/science/journal/09249338 ↗
http://www.elsevier.com/homepage/elecserv.htt ↗ - DOI:
- 10.1192/j.eurpsy.2022.2002 ↗
- Languages:
- English
- ISSNs:
- 0924-9338
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.842700
British Library HMNTS - ELD Digital store - Ingest File:
- 23309.xml